The 81st Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Luncheon Seminar

LS3-4 Current practice and future prospects of R/R ALL treatment with Inotuzumab Ozogamicin

Sun. Oct 13, 2019 12:25 PM - 1:10 PM No.4 (Tokyo International Forum, 5F Hall B5(1))

Chair: Masayuki Hino（Department of Hematology, Osaka City University）

Sponsor: Pfizer Japan Inc.

[LS3-4] Current practice and future prospects of R/R ALL treatment with Inotuzumab Ozogamicin

Yuho Najima (Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.Password is written on a program book.

Password